BNT-142

N/A

Report date: 2026/04/09 20:00:21

Base Information

Drug NameBNT-142
Drug Alias NameBNT-142
ClassificationCell and gene therapy > Gene therapy > mRNABiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > T cell engagers
Mechanisms of ActionT lymphocytes stimulantsCD3 T-cell engagersAnti-CLDN6
TargetsT cell surface glycoprotein CD3Claudin 6
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSingaporeGermany +[5] 
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBiontech Se
China Registration ClassN/A

Develop Information

Active CompaniesBiontech Se
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A